What is the best treatment approach for a patient with persistent Methicillin-Sensitive Staphylococcus Aureus (MSSA) bacteremia and an epidural abscess who is already on Nafcillin (Nafcillin)?

Management of Persistent MSSA Bacteremia with Epidural Abscess on Nafcillin

For persistent MSSA bacteremia with epidural abscess despite nafcillin therapy, you must immediately pursue aggressive source control through surgical drainage of the epidural abscess, continue nafcillin (as it has superior CNS penetration compared to cefazolin), and consider switching to high-dose daptomycin (8-10 mg/kg/day) if bacteremia persists beyond 48-72 hours despite adequate source control. 1, 2, 3

Critical First Steps

Immediate Source Control Assessment

• Surgical drainage of the epidural abscess is mandatory and the most critical intervention - persistent bacteremia in the setting of undrained deep-seated infection will lead to treatment failure regardless of antibiotic choice 2, 3
• Obtain urgent neurosurgical consultation for decompression and drainage, as medical therapy alone has high failure rates for spinal epidural abscess 4, 3
• Repeat imaging (MRI spine with contrast) to assess for additional metastatic foci including vertebral osteomyelitis, discitis, psoas abscess, or other deep collections 3

Verify Adequate Antibiotic Therapy

• Continue nafcillin as it is the preferred agent for MSSA with CNS involvement due to superior blood-brain barrier penetration compared to cefazolin 1, 5, 2
• Nafcillin dosing should be 2 g IV every 4 hours for severe deep-seated infections 1
• Do NOT add gentamicin - it provides no mortality benefit and significantly increases nephrotoxicity risk 1, 2

When to Switch Antibiotics

Indications for Changing from Nafcillin

• If bacteremia persists beyond 48-72 hours despite adequate source control, switch to high-dose daptomycin 8-10 mg/kg IV daily 2, 6
• High-dose daptomycin (10 mg/kg) combined with rifampin has demonstrated success in persistent MSSA bacteremia with multiple deep-seated foci including epidural abscess when standard therapy fails 6
• Daptomycin achieves better tissue penetration in complex infections and avoids the risk of developing resistance seen with standard dosing 6
• Obtain infectious diseases consultation for daptomycin dosing decisions 1

Alternative Considerations

• If nafcillin intolerance develops (not allergy), vancomycin 15-20 mg/kg IV every 8-12 hours is acceptable, though less effective than beta-lactams for MSSA 1, 2
• Do NOT use cefazolin for epidural abscess - it has inadequate blood-brain barrier penetration for CNS infections 1, 5

Duration of Therapy

Treatment Length

• Minimum 6 weeks of IV antibiotic therapy from the date of first negative blood culture for complicated MSSA bacteremia with epidural abscess 1, 2
• This represents complicated bacteremia with metastatic focus requiring extended therapy 2

Monitoring Response

• Obtain daily blood cultures until clearance is documented 2, 3
• Median time to clearance for MSSA is 4 days; persistent bacteremia beyond this suggests inadequate source control or treatment failure 7
• Persistent bacteremia ≥48 hours is associated with 39% 90-day mortality and mandates reassessment of source control 3

Common Pitfalls to Avoid

Critical Errors

• Failure to pursue adequate surgical drainage is the most common cause of treatment failure - antibiotics alone cannot sterilize undrained abscesses 2, 8, 3
• Using cefazolin instead of nafcillin for CNS/spinal infections results in inadequate CNS penetration 1, 5
• Adding gentamicin increases nephrotoxicity without improving outcomes 1, 2
• Stopping antibiotics prematurely before completing 6 weeks of therapy 1, 2

Additional Considerations

• Evaluate for endocarditis with transesophageal echocardiography given persistent bacteremia - this would extend treatment duration further 3
• Screen for additional metastatic foci (vertebral osteomyelitis, psoas abscess, septic arthritis) which occur in >33% of S. aureus bacteremia cases 3
• Consider rifampin addition only if switching to daptomycin for persistent infection, not with nafcillin monotherapy 2, 6